Royalty Pharma Ownership 2024 | Who Owns Royalty Pharma Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

14.32%

Insider Ownership

13.05%

Retail Ownership

72.63%

Institutional Holders

177.00

Royalty Pharma Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY9.84%0.09%44,133,446-84,439-0.19%1,163,799,031Jun 30, 2024
VANGUARD GROUP INC8.48%0.02%38,022,381322,6990.86%1,002,650,188Jun 30, 2024
FMR LLC6.22%0.05%27,886,701-5,747,515-17.09%735,372,306Jun 30, 2024
BLACKROCK INC.5.13%0.01%23,017,5611,811,7208.54%606,973,091Jun 30, 2024
BAILLIE GIFFORD & CO3.65%0.34%16,352,759-310,033-1.86%431,222,254Jun 30, 2024
VIKING GLOBAL INVESTORS LP2.67%1.21%11,970,058484,5114.22%315,650,429Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.2.44%0.53%10,931,931115,0001.06%288,275,020Jun 30, 2024
SWEDBANK AB2.41%0.38%10,813,4702,533,57030.60%285,151,204Jun 30, 2024
STATE STREET CORP2.11%0.01%9,486,811386,6634.25%250,167,206,000Jun 30, 2024
JPMORGAN CHASE & CO1.73%0.02%7,739,281-255,818-3.20%204,084,849Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.53%0.02%6,848,296300,2424.59%180,303,845Jun 30, 2024
UNISPHERE ESTABLISHMENT1.11%1.33%5,000,000--131,850,000Jun 30, 2024
NORGES BANK1.07%0.02%4,809,3434,809,343100.00%126,822,375Jun 30, 2024
SIGULER GUFF ADVISERS, LLC0.76%38.31%3,391,754--89,440,553Jun 30, 2024
NORTHERN TRUST CORP0.73%0.01%3,297,277484,14417.21%86,949,195,000Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.69%0.02%3,079,971179,2066.18%81,218,630Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.62%0.02%2,797,327933,60450.09%73,765,515Jun 30, 2024
GMT CAPITAL CORP0.54%2.37%2,427,100617,20034.10%64,002,627Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.52%0.03%2,350,280-2,316,866-49.64%61,976,884Jun 30, 2024
NEW SOUTH CAPITAL MANAGEMENT INC0.52%2.77%2,348,977887,52260.73%61,942,523Jun 30, 2024

Royalty Pharma's largest institutional shareholder is MORGAN STANLEY, holding 9.84% of the company's total share outstanding, currently valued at $1.16B. The top 10 institutional shareholders own together 44.66% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SIGULER GUFF ADVISERS, LLC0.76%38.31%3,391,754--89,440,553Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.26%5.88%1,181,332460,03163.78%31,151,725Jun 30, 2024
CUTTER CAPITAL MANAGEMENT, LP0.15%5.51%692,300280,76068.22%18,255,951Jun 30, 2024
ADVANCED PORTFOLIO MANAGEMENT, LLC0.05%4.17%240,000120,000100.00%6,328,800Jun 30, 2024
CM MANAGEMENT, LLC0.04%3.87%160,000--4,219,200Jun 30, 2024
REGAL PARTNERS LTD0.26%3.22%1,177,601217,77422.69%31,053,338Jun 30, 2024
NEW SOUTH CAPITAL MANAGEMENT INC0.52%2.77%2,348,977887,52260.73%61,942,523Jun 30, 2024
TORRAY INVESTMENT PARTNERS LLC0.15%2.73%693,55823,4983.51%18,289,124Jun 30, 2024
GMT CAPITAL CORP0.54%2.37%2,427,100617,20034.10%64,002,627Jun 30, 2024
MENLO ADVISORS LLC0.03%2.16%147,885147,885100.00%3,899,000Jun 30, 2024
PATIENT CAPITAL MANAGEMENT, LLC0.32%1.99%1,424,3904,5720.32%37,561,164Jun 30, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC0.42%1.81%1,866,361-384,000-17.06%49,215,940Jun 30, 2024
DARK FOREST CAPITAL MANAGEMENT LP0.08%1.63%338,675327,6592974.39%8,930,860Jun 30, 2024
RHENMAN & PARTNERS ASSET MANAGEMENT AB0.12%1.38%544,697--14,363,660Jun 30, 2024
OVERBROOK MANAGEMENT CORP0.04%1.33%200,412-8,937-4.27%5,284,864Jun 30, 2024
UNISPHERE ESTABLISHMENT1.11%1.33%5,000,000--131,850,000Jun 30, 2024
GENERAL ATLANTIC, L.P.0.33%1.24%1,500,000--39,555,000Jun 30, 2024
VIKING GLOBAL INVESTORS LP2.67%1.21%11,970,058484,5114.22%315,650,429Jun 30, 2024
HOMESTEAD ADVISERS CORP0.41%1.21%1,859,940-32,600-1.72%49,046,618Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.01%1.17%60,000--1,582,200Jun 30, 2024

The largest Royalty Pharma shareholder by % of total assets is SIGULER GUFF ADVISERS, LLC. The company owns 3.39M shares of Royalty Pharma (RPRX), representing 38.31% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK1.07%0.02%4,809,3434,809,343100.00%126,822,375Jun 30, 2024
SWEDBANK AB2.41%0.38%10,813,4702,533,57030.60%285,151,204Jun 30, 2024
BLACKROCK INC.5.13%0.01%23,017,5611,811,7208.54%606,973,091Jun 30, 2024
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC0.36%0.32%1,637,1951,637,195100.00%43,172,832Jun 30, 2024
INVESCO LTD.0.39%0.01%1,736,5211,062,833157.76%45,792,060Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC0.62%0.02%2,797,327933,60450.09%73,765,515Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.37%0.07%1,679,135908,455117.88%44,278,790Jun 30, 2024
NEW SOUTH CAPITAL MANAGEMENT INC0.52%2.77%2,348,977887,52260.73%61,942,523Jun 30, 2024
FIRST TRUST ADVISORS LP0.20%0.02%904,436879,6323546.33%23,849,996Jun 30, 2024
MAN GROUP PLC0.23%0.07%1,010,468813,343412.60%26,646,041Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.46%0.12%2,057,540753,88157.83%54,257,330Jun 30, 2024
GMT CAPITAL CORP0.54%2.37%2,427,100617,20034.10%64,002,627Jun 30, 2024
UBS GROUP AG0.29%0.01%1,285,120585,18583.61%33,888,614Jun 30, 2024
VIKING GLOBAL INVESTORS LP2.67%1.21%11,970,058484,5114.22%315,650,429Jun 30, 2024
NORTHERN TRUST CORP0.73%0.01%3,297,277484,14417.21%86,949,195,000Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.26%5.88%1,181,332460,03163.78%31,151,725Jun 30, 2024
RUSSELL INVESTMENTS GROUP, LTD.0.18%0.03%818,959416,816103.65%21,634,672Jun 30, 2024
DEUTSCHE BANK AG\0.22%0.01%979,784410,59072.14%25,836,905Jun 30, 2024
STATE STREET CORP2.11%0.01%9,486,811386,6634.25%250,167,206,000Jun 30, 2024
DARK FOREST CAPITAL MANAGEMENT LP0.08%1.63%338,675327,6592974.39%8,930,860Jun 30, 2024

As of Jun 30 2024, Royalty Pharma's largest institutional buyer is NORGES BANK. The company purchased 4.81M stocks of RPRX, valued at $126.82M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC6.22%0.05%27,886,701-5,747,515-17.09%735,372,306Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE0.06%0.01%279,852-2,934,926-91.29%7,379,697Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.52%0.03%2,350,280-2,316,866-49.64%61,976,884Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----521,200-100.00%-Jun 30, 2024
MARSHALL WACE, LLP0.21%0.03%945,840-510,060-35.03%24,941,801Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----477,047-100.00%-Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.0.16%0.11%714,404-437,367-37.97%18,838,833Jun 30, 2024
ROYAL BANK OF CANADA0.10%0.00%430,195-402,836-48.36%11,344,000Jun 30, 2024
HSBC HOLDINGS PLC0.12%0.01%524,814-399,619-43.23%13,813,104Jun 30, 2024
GENERATE INVESTMENT MANAGEMENT LTD----396,342-100.00%-Jun 30, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC0.42%1.81%1,866,361-384,000-17.06%49,215,940Jun 30, 2024
BAILLIE GIFFORD & CO3.65%0.34%16,352,759-310,033-1.86%431,222,254Jun 30, 2024
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM0.41%0.04%1,837,338-297,566-13.94%48,450,603Jun 30, 2024
PORTOLAN CAPITAL MANAGEMENT, LLC----288,378-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC0.07%0.00%319,182-283,806-47.07%8,416,830Jun 30, 2024
J. GOLDMAN & CO LP----265,334-100.00%-Jun 30, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC0.10%0.04%445,548-258,371-36.70%11,749,101Jun 30, 2024
JPMORGAN CHASE & CO1.73%0.02%7,739,281-255,818-3.20%204,084,849Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.08%0.01%349,748-254,997-42.17%9,222,855Jun 30, 2024
SQUAREPOINT OPS LLC0.09%0.02%401,526-222,513-35.66%10,588,241Jun 30, 2024

As of Jun 30 2024, Royalty Pharma's biggest institutional seller is FMR LLC. The company sold -5.75M shares of RPRX, valued at $735.37M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK1.07%0.02%4,809,3434,809,343100.00%126,822,375Jun 30, 2024
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC0.36%0.32%1,637,1951,637,195100.00%43,172,832Jun 30, 2024
MANNING & NAPIER ADVISORS LLC0.04%0.06%195,853195,853100.00%5,164,643Jun 30, 2024
MENLO ADVISORS LLC0.03%2.16%147,885147,885100.00%3,899,000Jun 30, 2024
HOHIMER WEALTH MANAGEMENT, LLC0.03%0.88%143,912143,912100.00%3,794,959Jun 30, 2024
CONCENTRIC CAPITAL STRATEGIES, LP0.02%0.13%100,968100,968100.00%2,662,526Jun 30, 2024
EMPLOYEES RETIREMENT SYSTEM OF TEXAS0.02%0.02%97,80097,800100.00%2,579,000Jun 30, 2024
DAI-ICHI LIFE INSURANCE COMPANY, LTD0.02%0.06%94,06694,066100.00%2,480,520Jun 30, 2024
OMERS ADMINISTRATION CORP0.02%0.02%81,01281,012100.00%2,136,286Jun 30, 2024
LIGHTHOUSE INVESTMENT PARTNERS, LLC0.02%0.08%75,10375,103100.00%1,980,466Jun 30, 2024
FJARDE AP-FONDEN (THE FOURTH SWEDISH NATIONAL PENSIONFUND)0.02%0.02%68,05068,050100.00%1,794,000Jun 30, 2024
AE WEALTH MANAGEMENT LLC0.01%0.02%62,99862,998100.00%1,661,266Jun 30, 2024
SEARLE & CO.0.01%0.36%57,50057,500100.00%1,516,275Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.01%0.00%48,19048,190100.00%1,270,770Jun 30, 2024
MAIN STREET FINANCIAL SOLUTIONS, LLC0.01%0.11%45,47045,470100.00%1,199,044Jun 30, 2024
BDF-GESTION0.01%0.10%38,18138,181100.00%1,006,833Jun 30, 2024
WALLEYE CAPITAL LLC0.01%0.00%37,63537,635100.00%992,435Jun 30, 2024
CREDIT AGRICOLE S A0.01%0.00%33,00033,000100.00%870,210Jun 30, 2024
MBB PUBLIC MARKETS I LLC0.01%0.01%27,11427,114100.00%714,996Jun 30, 2024
0.01%0.02%25,83325,833100.00%681,209Jun 30, 2024
KEYBANK NATIONAL ASSOCIATION/OH0.01%0.00%23,53323,533100.00%620,566Jun 30, 2024
LA BANQUE POSTALE ASSET MANAGEMENT SA0.00%0.02%20,01920,019100.00%527,901Jun 30, 2024
M&G PLC0.00%0.00%17,20017,200100.00%447,200Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.00%0.08%16,96816,968100.00%447,446Jun 30, 2024
FULLERTON FUND MANAGEMENT CO LTD.0.00%0.02%16,00216,002100.00%421,973Jun 30, 2024
CAPULA MANAGEMENT LTD0.00%0.00%15,47015,470100.00%407,944Jun 30, 2024
EPACRIA CAPITAL PARTNERS, LLC0.00%0.29%15,16415,164100.00%399,875Jun 30, 2024
AVANTAX ADVISORY SERVICES, INC.0.00%0.00%14,08914,089100.00%371,527Jun 30, 2024
APPLIED FINANCE CAPITAL MANAGEMENT, LLC0.00%0.02%12,89212,892100.00%339,962Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.18%11,40011,400100.00%300,618Jun 30, 2024
ENVESTNET PORTFOLIO SOLUTIONS, INC.0.00%0.00%9,6169,616100.00%253,576Jun 30, 2024
BLAIR WILLIAM & CO/IL0.00%0.00%8,4208,420100.00%222,035Jun 30, 2024
ONEASCENT WEALTH MANAGEMENT LLC0.00%0.11%7,9637,963100.00%210,000Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.00%0.00%4,9974,997100.00%131,771Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.00%0.00%3,0063,006100.00%79,268Jun 30, 2024
GLADIUS CAPITAL MANAGEMENT LP0.00%0.00%1,2081,208100.00%31,855Jun 30, 2024
ZYNERGYRETIREMENTPLANNINGLLC0.00%0.02%748748100.00%19,725Jun 30, 2024
WHITTIER TRUST CO0.00%0.00%484484100.00%12,758Jun 30, 2024
SRS CAPITAL ADVISORS, INC.-0.00%206206100.00%5,433Jun 30, 2024
PINERIDGE ADVISORS LLC-0.00%170170100.00%4,492Jun 30, 2024
ASHTON THOMAS PRIVATE WEALTH, LLC-0.00%147147100.00%3,876Jun 30, 2024
CORECAP ADVISORS, LLC-0.00%7373100.00%1,925Jun 30, 2024
CULLEN/FROST BANKERS, INC.--6060100.00%1,582Jun 30, 2024
CLARIVEST ASSET MANAGEMENT LLC-0.00%4949100.00%1,292Jun 30, 2024
ANCORA ADVISORS, LLC--2828100.00%738Jun 30, 2024
PENSERRA CAPITAL MANAGEMENT LLC--2727100.00%1,000Jun 30, 2024
GRADIENT INVESTMENTS LLC--1919100.00%501Jun 30, 2024
HARBOR INVESTMENT ADVISORY, LLC--44100.00%105Jun 30, 2024

Royalty Pharma's largest new institutional shareholder by number of shares is NORGES BANK, purchased 4.81M shares, valued at $126.82M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
POINT72 ASSET MANAGEMENT, L.P.----521,200-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----477,047-100.00%-Jun 30, 2024
GENERATE INVESTMENT MANAGEMENT LTD----396,342-100.00%-Jun 30, 2024
PORTOLAN CAPITAL MANAGEMENT, LLC----288,378-100.00%-Jun 30, 2024
J. GOLDMAN & CO LP----265,334-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----137,000-100.00%-Jun 30, 2024
HRT FINANCIAL LP----130,188-100.00%-Jun 30, 2024
MYCIO WEALTH PARTNERS, LLC----113,652-100.00%-Jun 30, 2024
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC----92,452-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----75,000-100.00%-Jun 30, 2024
CORNERCAP INVESTMENT COUNSEL INC----67,314-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----65,582-100.00%-Jun 30, 2024
TAIKA CAPITAL, LP----43,740-100.00%-Jun 30, 2024
WEALTHFRONT ADVISERS LLC----33,821-100.00%-Jun 30, 2024
LINDEN THOMAS ADVISORY SERVICES, LLC----33,674-100.00%-Jun 30, 2024
TWIN TREE MANAGEMENT, LP----33,000-100.00%-Jun 30, 2024
FINANCIERE DES PROFESSIONNELS - FONDS D,INVESTISSEMENT INC.----32,931-100.00%-Jun 30, 2024
SYSTM WEALTH SOLUTIONS LLC----32,836-100.00%-Jun 30, 2024
ADVISORY RESOURCE GROUP----27,121-100.00%-Jun 30, 2024
POINT72 HONG KONG LTD----26,789-100.00%-Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----22,866-100.00%-Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC----17,841-100.00%-Jun 30, 2024
AGF MANAGEMENT LTD----16,657-100.00%-Jun 30, 2024
ADVISORSHARES INVESTMENTS LLC----15,717-100.00%-Jun 30, 2024
CLEARALPHA TECHNOLOGIES LP----13,137-100.00%-Jun 30, 2024
BALLENTINE PARTNERS, LLC----12,541-100.00%-Jun 30, 2024
DIAMETRIC CAPITAL, LP----11,851-100.00%-Jun 30, 2024
ASB CONSULTORES, LLC----11,798-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----11,200-100.00%-Jun 30, 2024
KOSHINSKI ASSET MANAGEMENT, INC.----10,671-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----10,190-100.00%-Jun 30, 2024
SAYBROOK CAPITAL /NC----9,000-100.00%-Jun 30, 2024
SCIENTECH RESEARCH LLC----8,973-100.00%-Jun 30, 2024
ETHIC INC.----8,745-100.00%-Jun 30, 2024
AXQ CAPITAL, LP----7,900-100.00%-Jun 30, 2024
US FINANCIAL ADVISORS, LLC----7,815-100.00%-Jun 30, 2024
TEZA CAPITAL MANAGEMENT LLC----7,576-100.00%-Jun 30, 2024
LAKE STREET ADVISORS GROUP, LLC----7,464-100.00%-Jun 30, 2024
COMMERCE BANK----7,379-100.00%-Jun 30, 2024
ARGENT TRUST CO----7,259-100.00%-Jun 30, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC----7,197-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----6,800-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----6,672-100.00%-Jun 30, 2024
FIRST MANHATTAN CO. LLC.----3,500-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----3,059-100.00%-Jun 30, 2024
GRAYHAWK INVESTMENT STRATEGIES INC.----1,844-100.00%-Jun 30, 2024
FIDELIS CAPITAL PARTNERS, LLC----1,518-100.00%-Jun 30, 2024
JOHNSON FINANCIAL GROUP, INC.----350-100.00%-Jun 30, 2024
MEEDER ASSET MANAGEMENT INC----204-100.00%-Jun 30, 2024
BARTLETT & CO. WEALTH MANAGEMENT LLC----95-100.00%-Jun 30, 2024
FIRST PACIFIC FINANCIAL----87-100.00%-Jun 30, 2024
FINANCIAL SYNERGIES WEALTH ADVISORS, INC.----51-100.00%-Jun 30, 2024
WR WEALTH PLANNERS, LLC----49-100.00%-Jun 30, 2024
ADVISORNET FINANCIAL, INC----10-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----2-100.00%-Jun 30, 2024

Royalty Pharma's largest sold out institutional shareholder by shares sold is POINT72 ASSET MANAGEMENT, L.P., sold -0.52M shares, valued at -, as of undefined.

Royalty Pharma Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS1.92%1,000,000--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS1.53%800,000--Mar 31, 2024
Tax-Managed Multi-Cap Growth Portfolio1.33%35,581--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.96%500,000--Mar 31, 2024
DELAWARE GROUP INCOME FUNDS0.78%25,011,000--Jan 31, 2024
DELAWARE VIP TRUST0.71%2,570,000--Mar 28, 2024
FRANKLIN STRATEGIC SERIES0.62%5,300,000--Jan 31, 2024
FRANKLIN STRATEGIC SERIES0.62%5,300,000--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.51%265,850--Mar 31, 2024
Nuveen Core Equity Alpha Fund0.49%35,000--Mar 31, 2024
ADVENT CONVERTIBLE & INCOME FUND0.48%1,659,000--Jan 31, 2024
PUTNAM GLOBAL HEALTH CARE FUND0.40%653,600--Feb 29, 2024
BNY Mellon Investment Funds VII, Inc.0.31%325,000--Jan 31, 2024
Ivy Variable Insurance Portfolios0.29%6,638,0002,335,00054.26%Mar 28, 2024
BNY Mellon Investment Funds VII, Inc.0.28%325,000--Apr 30, 2022
PUTNAM FOCUSED INTERNATIONAL EQUITY FUND0.28%168,402--Jan 31, 2024
BNY Mellon Absolute Insight Funds, Inc.0.28%4,242,000--Apr 30, 2022
Humankind Benefit Corp0.27%5,9625249.64%Dec 31, 2023
BNY Mellon Investment Funds VI0.25%325,000325,000-Feb 29, 2024
ULTRA SERIES FUND0.25%450,000--Mar 31, 2024
PPM Funds0.23%184,000--Mar 31, 2024
BNY Mellon Absolute Insight Funds, Inc.0.23%4,242,000--Jan 31, 2024
CALVERT VARIABLE SERIES INC0.22%431,000--Mar 31, 2024
Natixis ETF Trust0.22%45,000--Mar 31, 2024
DELAWARE GROUP ADVISER FUNDS0.22%9,196,000--Jan 31, 2024
DOMINI INVESTMENT TRUST0.21%1,250,000--Jan 31, 2024
DOMINI INVESTMENT TRUST0.21%1,250,000--Jan 31, 2024
Core Bond Portfolio0.21%1,588,000--Mar 31, 2024
ALGER FUNDS II0.19%43,026--Jan 31, 2024
Nuveen S&P 500 Dynamic Overwrite Fund0.18%5,318--Mar 31, 2024
OPTIMUM FUND TRUST0.17%7,625,000--Mar 28, 2024
CALVERT VARIABLE SERIES INC0.17%332,000--Mar 31, 2024
Federated Hermes Total Return Series, Inc.0.17%21,600,000--Feb 29, 2024
CALVERT SOCIAL INVESTMENT FUND0.17%7,640,000--Mar 31, 2024
Virtus Global Multi-Sector Income Fund0.17%258,000--Feb 29, 2024
DELAWARE GROUP EQUITY FUNDS IV0.16%190,000--Mar 28, 2024
Core Bond Portfolio0.16%1,222,000--Mar 31, 2024
PPM Funds0.16%125,000--Mar 31, 2024
DELAWARE VIP TRUST0.15%545,000--Mar 28, 2024
FEDERATED HERMES INSURANCE SERIES0.15%670,000--Mar 31, 2024
MORGAN STANLEY VARIABLE INVESTMENT SERIES0.14%75,000--Jun 30, 2023
MORGAN STANLEY VARIABLE INVESTMENT SERIES0.14%75,000--Jun 30, 2023
Virtus Total Return Fund Inc.0.14%271,000--Feb 29, 2024
VANGUARD WELLESLEY INCOME FUND0.14%48,265,000--Mar 31, 2024
VANGUARD WELLESLEY INCOME FUND0.14%48,265,000-48,265,000-50.00%Mar 31, 2024
ULTRA SERIES FUND0.14%250,000--Mar 31, 2024
JANUS ASPEN SERIES0.13%5,695,000--Dec 31, 2023
CALVERT SOCIAL INVESTMENT FUND0.13%5,884,000--Mar 31, 2024
ADVISORS' INNER CIRCLE FUND0.13%3,158,000--Jan 31, 2024
MADISON FUNDS0.13%750,000--Jan 31, 2024
BNY Mellon Absolute Insight Funds, Inc.0.12%2,258,000--Jan 31, 2024
ADVISORS' INNER CIRCLE FUND0.12%2,918,000--Jan 31, 2024
BlackRock Multi-Sector Opportunities Trust0.11%195,000--Dec 31, 2023
BlackRock Multi-Sector Opportunities Trust0.11%195,000--Dec 31, 2023
PPM Funds0.11%91,000--Mar 31, 2024
GUGGENHEIM STRATEGIC OPPORTUNITIES FUND0.11%2,100,000--Feb 29, 2024
GUGGENHEIM STRATEGIC OPPORTUNITIES FUND0.11%2,100,000--Feb 29, 2024
VANGUARD WELLINGTON FUND0.11%44,555,000--Feb 29, 2024
VIRTUS VARIABLE INSURANCE TRUST0.10%162,000--Mar 28, 2024
DELAWARE GROUP INCOME FUNDS0.10%3,175,000--Jan 31, 2024
Columbia Funds Variable Series Trust II0.10%3,185,000--Mar 31, 2024
Engine No. 1 ETF Trust0.09%5,562-144-2.52%Jan 31, 2024
JANUS ASPEN SERIES0.09%3,923,000--Dec 31, 2023
AMG Funds IV0.09%265,000--Jan 31, 2024
Ultimus Managers Trust0.09%1,000,000--Feb 29, 2024
MADISON FUNDS0.09%500,000--Jan 31, 2024
DELAWARE GROUP ADVISER FUNDS0.08%3,376,000--Jan 31, 2024
AdvisorShares Trust0.08%323,000--Mar 28, 2024
Invesco Bond Fund0.08%146,000--Feb 29, 2024
Guggenheim Variable Funds Trust0.08%310,000--Dec 31, 2023
Guggenheim Variable Funds Trust0.08%310,000--Dec 31, 2023
VANGUARD INDEX FUNDS0.08%32,164,819-6,045,366-15.82%Mar 31, 2024
GUGGENHEIM FUNDS TRUST0.07%42,610,000--Dec 31, 2023
GUGGENHEIM FUNDS TRUST0.07%42,400,000--Dec 31, 2023
JANUS INVESTMENT FUND0.07%22,254,000--Dec 31, 2023
BlackRock Multi-Sector Opportunities Trust II0.07%85,000--Sep 30, 2023
BlackRock Multi-Sector Opportunities Trust II0.07%85,000--Sep 30, 2023
JANUS ASPEN SERIES0.07%3,046,000--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.07%72,542,000-11,350,000-13.53%Jan 31, 2024
Nuveen NASDAQ 100 Dynamic Overwrite Fund0.07%8,196--Mar 31, 2024
Invesco Bond Fund0.07%126,000--Feb 29, 2024
CALVERT FUND0.07%4,000,000--Mar 31, 2024
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.07%166,000--Mar 31, 2024
DELAWARE POOLED TRUST0.07%70,000--Jan 31, 2024
AMERICAN CENTURY INVESTMENT TRUST0.06%9,163,000--Mar 31, 2024
ALLSPRING MASTER TRUST0.06%4,172,000--Feb 29, 2024
PPM Funds0.06%50,000--Mar 31, 2024
Federated Hermes Managed Pool Series0.06%790,000--Mar 31, 2024
VANGUARD HORIZON FUNDS0.06%1,411,683-49,015-3.36%Mar 31, 2024
DOMINI INVESTMENT TRUST0.06%350,000--Jan 31, 2024
Calvert Management Series0.06%598,000--Mar 31, 2024
Forethought Variable Insurance Trust0.06%245,000--Mar 28, 2024
STATE STREET INSTITUTIONAL FUNDS0.06%45,000--Mar 31, 2024
VANGUARD SPECIALIZED FUNDS0.06%3,053,455--Jan 31, 2024
VIRTUS OPPORTUNITIES TRUST0.05%13,644,000--Feb 29, 2024
JOHN HANCOCK INCOME SECURITIES TRUST0.05%157,000--Jan 31, 2024
JOHN HANCOCK INCOME SECURITIES TRUST0.05%157,000--Jan 31, 2024
CALVERT FUND0.05%2,772,000--Mar 31, 2024
JANUS INVESTMENT FUND0.05%14,211,000--Dec 31, 2023
Voya BALANCED PORTFOLIO INC0.05%68,000--Mar 31, 2024

Royalty Pharma's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 1.00M shares, compromising 1.92% of its total assets.

Royalty Pharma Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24177-53.79%
31 Mar, 243834.64%
31 Dec, 2336614.73%
30 Sep, 23319-3.04%
30 Jun, 23329-0.60%
31 Mar, 23331-1.49%
31 Dec, 223366.33%
30 Sep, 2231610.49%
30 Jun, 222861.42%
31 Mar, 222824.06%
31 Dec, 2127112.45%
30 Sep, 21241-0.41%
30 Jun, 2124211.01%
31 Mar, 212188.46%
31 Dec, 2020145.65%
30 Sep, 2013810.40%
30 Jun, 2012512400.00%
31 Mar, 201-
31 Dec, 191-
30 Sep, 191-
30 Jun, 191-
31 Mar, 191-

As of 30 Jun 24, 177 institutions are holding Royalty Pharma's shares, representing a decrease of -53.79% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2464,248,678-79.10%
31 Mar, 24307,482,5140.71%
31 Dec, 23305,308,2754.62%
30 Sep, 23291,835,068-6.34%
30 Jun, 23311,586,2984.53%
31 Mar, 23298,094,2980.35%
31 Dec, 22297,069,2060.36%
30 Sep, 22296,001,8951.94%
30 Jun, 22290,377,1307.77%
31 Mar, 22269,435,7790.69%
31 Dec, 21267,599,5361.39%
30 Sep, 21263,941,4785.79%
30 Jun, 21249,496,7090.94%
31 Mar, 21247,181,1247.47%
31 Dec, 20230,000,93244.50%
30 Sep, 20159,167,6086.05%
30 Jun, 20150,086,3461000575540.00%
31 Mar, 2015-
31 Dec, 1915-
30 Sep, 1915-
30 Jun, 1915-
31 Mar, 1915-

Royalty Pharma (RPRX) has 64.25M shares outstanding as of 30 Jun 24, down -79.10% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2414.32%0.30%
31 Mar, 2468.70%1.48%
31 Dec, 2368.08%1.62%
30 Sep, 2364.79%1.33%
30 Jun, 2369.92%1.56%
31 Mar, 2366.90%1.45%
31 Dec, 2267.83%1.49%
30 Sep, 2267.38%1.52%
30 Jun, 2266.55%1.73%
31 Mar, 2262.09%1.59%
31 Dec, 2162.49%1.64%
30 Sep, 2161.64%1.66%
30 Jun, 2160.95%1.52%
31 Mar, 2163.42%1.81%
31 Dec, 2059.26%3.20%
30 Sep, 2043.02%2.39%
30 Jun, 2042.40%-
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 19--

As of 30 Jun 24, Royalty Pharma is held by 14.32% institutional shareholders, representing a 0.30% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2492-57.99%
31 Mar, 24219-2.67%
31 Dec, 2322532.35%
30 Sep, 23170-6.59%
30 Jun, 23182-1.09%
31 Mar, 23184-3.16%
31 Dec, 221907.95%
30 Sep, 221769.32%
30 Jun, 22161-10.06%
31 Mar, 221797.83%
31 Dec, 2116626.72%
30 Sep, 21131-7.75%
30 Jun, 211427.58%
31 Mar, 21132-17.50%
31 Dec, 2016066.67%
30 Sep, 2096-20.66%
30 Jun, 20121-
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--100.00%
31 Mar, 191-

92 institutional shareholders have increased their position in RPRX stock as of 30 Jun 24 compared to 219 in the previous quarter (a -57.99% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2454-53.45%
31 Mar, 241167.41%
31 Dec, 23108-6.09%
30 Sep, 231157.48%
30 Jun, 231075.94%
31 Mar, 23101-0.98%
31 Dec, 2210215.91%
30 Sep, 228811.39%
30 Jun, 227931.67%
31 Mar, 2260-10.45%
31 Dec, 2167-12.99%
30 Sep, 217728.33%
30 Jun, 21609.09%
31 Mar, 2155129.17%
31 Dec, 202433.33%
30 Sep, 2018-
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 19--

54 institutional shareholders have reduced their position in RPRX stock as of 30 Jun 24 compared to 116 in the previous quarter (a -53.45% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24177-53.79%64,248,678-79.10%14.32%0.30%92-57.99%54-53.45%
31 Mar, 243834.64%307,482,5140.71%68.70%1.48%219-2.67%1167.41%
31 Dec, 2336614.73%305,308,2754.62%68.08%1.62%22532.35%108-6.09%
30 Sep, 23319-3.04%291,835,068-6.34%64.79%1.33%170-6.59%1157.48%
30 Jun, 23329-0.60%311,586,2984.53%69.92%1.56%182-1.09%1075.94%
31 Mar, 23331-1.49%298,094,2980.35%66.90%1.45%184-3.16%101-0.98%
31 Dec, 223366.33%297,069,2060.36%67.83%1.49%1907.95%10215.91%
30 Sep, 2231610.49%296,001,8951.94%67.38%1.52%1769.32%8811.39%
30 Jun, 222861.42%290,377,1307.77%66.55%1.73%161-10.06%7931.67%
31 Mar, 222824.06%269,435,7790.69%62.09%1.59%1797.83%60-10.45%
31 Dec, 2127112.45%267,599,5361.39%62.49%1.64%16626.72%67-12.99%
30 Sep, 21241-0.41%263,941,4785.79%61.64%1.66%131-7.75%7728.33%
30 Jun, 2124211.01%249,496,7090.94%60.95%1.52%1427.58%609.09%
31 Mar, 212188.46%247,181,1247.47%63.42%1.81%132-17.50%55129.17%
31 Dec, 2020145.65%230,000,93244.50%59.26%3.20%16066.67%2433.33%
30 Sep, 2013810.40%159,167,6086.05%43.02%2.39%96-20.66%18-
30 Jun, 2012512400.00%150,086,3461000575540.00%42.40%-121---
31 Mar, 201-15-------
31 Dec, 191-15-------
30 Sep, 191-15-------
30 Jun, 191-15-----100.00%--
31 Mar, 191-15---1---

Royalty Pharma Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 04, 2024RIGGS RORY Bdirector-S-SaleSell235,200$28.52$6.71M254,899
Jan 04, 2024RIGGS RORY Bdirector-S-SaleSell199,098$27.79$5.53M55,801

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024Coyne Terrance P.officer EVP & CFOG-GiftSell2,000--44,350
Aug 12, 2024Lloyd George W.officer EVP, Investments & CLOG-GiftSell7,920---
Aug 12, 2024Urist Marshallofficer EVP, Research & InvestmentsG-GiftSell2,182--126,412
May 16, 2024Hite Christopherofficer EVP & Vice ChairmanC-ConversionSell30,000--541
Feb 22, 2024RIGGS RORY Bdirector-C-ConversionSell30,000--270,000
Jan 04, 2024RIGGS RORY Bdirector-S-SaleSell235,200$28.52$6.71M254,899
Jan 04, 2024RIGGS RORY Bdirector-S-SaleSell199,098$27.79$5.53M55,801

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024Coyne Terrance P.officer EVP & CFOG-GiftSell2,000--44,350
Aug 12, 2024Lloyd George W.officer EVP, Investments & CLOG-GiftSell7,920---
Aug 12, 2024Urist Marshallofficer EVP, Research & InvestmentsG-GiftSell2,182--126,412
Jun 28, 2024Fernandez Henry Adirector-A-AwardBuy1,399$26.80$37.49K52,660
Jun 28, 2024Bassler Bonnie Ldirector-A-AwardBuy1,399$26.80$37.49K58,454
Jun 10, 2024Norden Gregorydirector-A-AwardBuy9,293--73,738
Jun 10, 2024LOVE TED Wdirector-A-AwardBuy9,293--46,234
Jun 10, 2024HODGSON DAVID Cdirector-A-AwardBuy9,293--25,714
Jun 10, 2024Fernandez Henry Adirector-A-AwardBuy9,293--51,261
Jun 10, 2024Engelbert Catherine M.director-A-AwardBuy9,293--43,514
Jun 10, 2024DESOUZA ERROL Bdirector-A-AwardBuy9,293--73,738
Jun 10, 2024Bassler Bonnie Ldirector-A-AwardBuy9,293--57,055
May 16, 2024Hite Christopherofficer EVP & Vice ChairmanC-ConversionBuy300,000--370,000
May 16, 2024Hite Christopherofficer EVP & Vice ChairmanC-ConversionSell30,000--541
Apr 02, 2024Fernandez Henry Adirector-A-AwardBuy1,240$30.23$37.48K41,968
Apr 02, 2024Bassler Bonnie Ldirector-A-AwardBuy1,240$30.23$37.48K47,762
Feb 22, 2024RIGGS RORY Bdirector-C-ConversionBuy300,000--320,099
Feb 22, 2024RIGGS RORY Bdirector-C-ConversionSell30,000--270,000
Jan 04, 2024RIGGS RORY Bdirector-S-SaleSell235,200$28.52$6.71M254,899
Jan 04, 2024RIGGS RORY Bdirector-S-SaleSell199,098$27.79$5.53M55,801

The last insider sell of Royalty Pharma's stock was made by Coyne Terrance P. on Aug 12 2024, selling 2,000 shares at - per share (valued at -).

Royalty Pharma Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-3-
Q2 20241011000.00%
Q1 20243475.00%
Q4 20234944.44%
Q3 20232728.57%
Q2 2023197271.43%
Q1 20234850.00%
Q4 202231323.08%
Q3 20223368.33%
Q2 202291464.29%
Q1 20225862.50%
Q4 202161931.58%
Q3 202153016.67%
Q2 2021224746.81%
Q1 202151729.41%
Q4 2020121770.59%
Q3 202052250.00%
Q2 20206919363.16%
Q1 2018-6-
Q3 20172--

0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Royalty Pharma's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024---
Q1 2024-3-
Q4 2023-6-
Q3 2023-4-
Q2 202365120.00%
Q1 2023-6-
Q4 2022-13-
Q3 2022-33-
Q2 2022-11-
Q1 20221520.00%
Q4 2021-13-
Q3 2021-24-
Q2 2021-39-
Q1 20211175.88%
Q4 2020-4-
Q3 2020---
Q2 202010--
Q1 2018---
Q3 2017---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Royalty Pharma's stocks.

Royalty Pharma Peer Ownership


TickerCompany
AKROAkero Therapeutics, Inc.
DNAGinkgo Bioworks Holdings, Inc.
ADPTAdaptive Biotechnologies Corporation
VECTVectivBio Holding AG
IKNAIkena Oncology, Inc.
IOVAIovance Biotherapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
DAWNDay One Biopharmaceuticals, Inc.
RPHMReneo Pharmaceuticals, Inc.
CVACCureVac N.V.
BGNEBeiGene, Ltd.
PRMEPrime Medicine, Inc.
KNTEKinnate Biopharma Inc.
ASNDAscendis Pharma A/S
OCEAOcean Biomedical, Inc.
KRTXKaruna Therapeutics, Inc.
MDGLMadrigal Pharmaceuticals, Inc.
AMLXAmylyx Pharmaceuticals, Inc.

RPRX Ownership FAQ


Royalty Pharma is owned by institutional shareholders (14.32%), insiders (13.05%), and public (72.63%). The largest institutional shareholder of Royalty Pharma is MORGAN STANLEY (9.84% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (1.92% of total shares).

Royalty Pharma's major institutional shareholders are MORGAN STANLEY, VANGUARD GROUP INC, FMR LLC, BLACKROCK INC., and BAILLIE GIFFORD & CO. The top five shareholders own together 33.30% of the company's share outstanding.

As of Jun 2024, there are 177 institutional shareholders of Royalty Pharma.

MORGAN STANLEY owns 44.13M shares of Royalty Pharma, representing 9.84% of the company's total shares outstanding, valued at $1.16B (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 38.02M shares of Royalty Pharma (RPRX), compromising 8.48% of the company, valued at $1B.

FMR LLC is the third largest holder of Royalty Pharma. The company owns 27.89M of the company's shares outstanding (worth $735.37M).